机译:BET抑制剂在MLL-AF4(+)刺婴儿的临床前小鼠模型中BET抑制剂的抗血尿疗效
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Univ Padua Dept Woman &
Child Hlth Padua Italy;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Sophia Childrens Univ Hosp Erasmus MC Dept Pediat Oncol Hematol Rotterdam Netherlands;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Sophia Childrens Univ Hosp Erasmus MC Dept Pediat Oncol Hematol Rotterdam Netherlands;
Sophia Childrens Univ Hosp Erasmus MC Dept Pediat Oncol Hematol Rotterdam Netherlands;
GlaxoSmithKline Epinova DPU Immunoinflammat Therapy Area Med Res Ctr Stevenage Herts England;
GlaxoSmithKline Epinova DPU Immunoinflammat Therapy Area Med Res Ctr Stevenage Herts England;
Univ Padua Dept Woman &
Child Hlth Padua Italy;
Univ Padua Dept Woman &
Child Hlth Padua Italy;
Sophia Childrens Univ Hosp Erasmus MC Dept Pediat Oncol Hematol Rotterdam Netherlands;
Princess Maxima Ctr Pediat Oncol Utrecht Netherlands;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
Univ Milano Bicocca Ctr Ric Tettamanti Pediat Clin Fdn MBBM Monza Italy;
机译:BET抑制剂在MLL-AF4(+)刺婴儿的临床前小鼠模型中BET抑制剂的抗血尿疗效
机译:ALK-2抑制剂TP-0184在肝脏的高度分布中表现出高度的分布,对慢性疾病性贫血小鼠模型的重要临床前疗效有贡献
机译:JAK1 / 2和泛脱乙酰基酶抑制剂联合治疗在JAK2V617F驱动的疾病的临床前小鼠模型中产生更高的疗效
机译:hu-m? Ciea nog鼠标?:一种新型临床前平台,用于测试治疗患者对癌症和传染病的疗效
机译:elF4E抑制剂Briciclib(在013105上)在各种临床前癌症模型中均显示出强大的抗癌活性。
机译:c-Met抑制剂CE-355621在用18F-FDG小动物PET评估的U87 MG小鼠异种移植模型中的临床前功效
机译:BET抑制剂在MLL-AF4 +婴儿临床前小鼠模型中的抗血尿抑制剂